UK Life Sciences and Healthcare Newsletter

January 28, 2021

We are pleased to present the January issue of Dechert LLP’s UK Life Sciences and Healthcare Newsletter.

This month's Newsletter provides an insight into current developments, analysis and news, including:

An update in relation to the recently published report by the European Union Intellectual Property Office and Organisation for Economic Co-Operation and Development regarding counterfeit pharmaceuticals
An update on the UK government's recent launch of a consultation into potential reforms to post-termination non-compete clauses in employment contracts
A panel discussion on the healthcare investment landscape post COVID-19
A guest contributor feature from AXA IM Framlington's Co-head of Global Equities Linden Thomson: "All Eyes Were on Biotech in 2020: Some Investor Observations"

Read the 'UK Life Sciences and Healthcare Newsletter.'